-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Esophageal cancer is one of the leading causes of cancer-related deaths in the world
The survival outcome of patients with esophageal squamous cell carcinoma (ESCC) treated with thoracotomy or thoracoscopic esophagectomy is unclear
This study aimed to compare the overall survival prognosis of ESCC patients who did not receive neoadjuvant CRT treated with thoracotomy or thoracoscopic esophagectomy
The researchers investigated ESCC cases from the Taiwan Cancer Registry from 2008 to 2016, and included 2053 ESCC patients who underwent open thoracoesophagectomy (n=645) or thoracoscopic esophagectomy (n=1408)
The overall survival rate of all patients treated with two types of surgery
The overall survival rate of all patients treated with two types of surgeryAfter 1:2 propensity score matching, a total of 1299 ESCC patients with comparable clinicopathological characteristics were identified
The 3-year overall survival rate of matched patients in the thoracoscopy group was better than that of the thoracotomy group (58.
Overall survival rate of matched patients treated with two types of surgery
Overall survival rate of matched patients treated with two types of surgeryA stage-specific comparison shows that the survival rate of patients with pathological stage I/II ESCC who undergoes thoracoscopic esophagectomy is higher than that of patients who undergo thoracotomy esophagectomy
The survival rate of patients with pathological stage I/II ESCC who undergoes thoracoscopic esophagectomy is higher than that of patients who undergo thoracotomy esophagectomy
In summary, this trend-matching study shows that for ESCC patients who have not undergone neoadjuvant CRT, thoracoscopic esophagectomy can provide a higher survival rate than thoracotomy esophagectomy
For ESCC patients without neoadjuvant CRT, thoracoscopic esophagectomy can provide a higher survival rate than thoracotomy.
Original source:
Wang Bing-Yen,Lin Ching-Hsiung,Wu Shiao-Chi et al.
Survival Comparison Between Open and Thoracoscopic Upfront Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma
in this message